Expand UTHR Menu
UTHR MENU

UTHR Stock Posts


Unusual Option Volume

UTHR United Therapeutics477.80-7.74 (-1.6%)

United Therapeutics trades 16,769 contracts. The company has the following event: Presentation of Full Phase 1 Study Results of miroliverELAP in Acute Liver Failure Patients between Jul 1, 2026 and Dec 31, 2026.
View Details...
Unusual Option Volume

UTHR United Therapeutics496.07-1.20 (-0.2%)

United Therapeutics trades 70,083 contracts. The company has the following event: Presentation of Full Phase 1 Study Results of miroliverELAP in Acute Liver Failure Patients between Jul 1, 2026 and Dec 31, 2026.
View Details...
Unusual Option Volume

UTHR United Therapeutics525.68+7.41 (+1.4%)

United Therapeutics trades 12,021 contracts. The company has the following event: Presentation of Full Phase 1 Study Results of miroliverELAP in Acute Liver Failure Patients between Jul 1, 2026 and Dec 31, 2026.
View Details...
Unusual Option Volume

UTHR United Therapeutics508.14+8.41 (+1.7%)

United Therapeutics trades 66,953 contracts. The company has the following event: Presentation of Full Phase 1 Study Results of miroliverELAP in Acute Liver Failure Patients between Jul 1, 2026 and Dec 31, 2026. News: United Therapeutics Corporation Announces Full Enrollment of the TETON-PPF Study of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis
View Details...
Unusual Option Volume

UTHR United Therapeutics521.60+2.59 (+0.5%)

United Therapeutics trades 15,199 contracts. The company has the following event: Presentation of Full Phase 1 Study Results of miroliverELAP in Acute Liver Failure Patients between Jul 1, 2026 and Dec 31, 2026.
View Details...
Unusual Option Volume

UTHR United Therapeutics518.16-5.47 (-1.0%)

United Therapeutics trades 5,716 contracts. The highest volume is in the 21-Aug-26 470 puts. News: United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Published in The Lancet
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes